BioLeap
Latest round
- Series A
Last raised
- Jan 2010
Total raised
- $5M
Investors
- 2
About BioLeap
BioLeap is based in Ewing, US and is a drug design company that identifies and optimizes lead compounds using its proprietary technology platform.
Who invested in BioLeap
2 investors across 1 round
See all investors in BioLeap
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 12, 2010
Amount
$5M
Investors
Questions about BioLeap
Who invested in BioLeap?
BioLeap has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioLeap raised?
BioLeap has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioLeap last raise money?
BioLeap's most recent round on record is a Series A, in Jan 2010.
What does BioLeap do?
BioLeap is based in Ewing, US and is a drug design company that identifies and optimizes lead compounds using its proprietary technology platform.
Where is BioLeap headquartered?
BioLeap is headquartered in Ewing, US.
Which VCs invest in companies like BioLeap?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at BioLeap's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like BioLeap? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.